Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Non-Muscle Invasive Bladder Neoplasms × tremelimumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Liver Neoplasms 2 Carcinoma, Hepatocellular 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Non Small Cell Lung Cancer NSCLC 1 Mesothelioma, Malignant 1 Lung Neoplasms 1 Lung Cancer Metastatic 1 Hydronephrosis 1 Fallopian Tube Neoplasms 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Adenocarcinoma, Follicular 1

Interventions

Gemcitabine 7 erdafitinib 4 Mitomycin 4 dodecyl maltoside 2 Docetaxel 2 pirarubicin 1 hydroxycamptothecinum 1 Transurethral Resection of Bladder 1 Patient Discharge 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Injections 1 Epirubicin 1 Drainage 1 Cystoscopy 1 BCG Vaccine 1 Accelerometry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡